https://www.pharmaglobenewswire.com/laryngeal-cancer-market-is-projected-to-grow-at-a-significant-cagr-through-2034-estimates-delveinsight/Pharma Globenewswireen2026-06-11T13:07:14+01:00Laryngeal Cancer Market is Projected to Grow at a Significant CAGR Through 2034, Estimates DelveInsight https://www.pharmaglobenewswire.com/presbyopia-clinical-trial-pipeline-gains-momentum-6-companies-lead-the-charge-in-pioneering-new-treatments/Pharma Globenewswireen2026-06-11T11:18:24+01:00Presbyopia Clinical Trial Pipeline Gains Momentum: 6+ Companies Lead the Charge in Pioneering New Treatments https://www.pharmaglobenewswire.com/myelofibrosis-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2036/Pharma Globenewswireen2026-06-11T10:56:42+01:00Myelofibrosis Market Set to Witness Significant Growth Driven by Rising Prevalence, Pipeline Advancements, and Expanding Therapeutic Options Through 2036 https://www.pharmaglobenewswire.com/tyk2-inhibitor-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/Pharma Globenewswireen2026-06-10T13:02:05+01:00TYK2 Inhibitor Market Size in the 7MM is projected to grow at a significant CAGR by 2034, according to DelveInsight https://www.pharmaglobenewswire.com/interleukin-23-inhibitors-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/Pharma Globenewswireen2026-06-10T11:59:04+01:00Interleukin-23 Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR by 2034, according to DelveInsight https://www.pharmaglobenewswire.com/the-epilepsy-market-size-across-the-7mm-was-valued-at-nearly-usd-9-billion-in-2023-and-is-expected-to-grow-at-a-cagr-of-7-during-2026-2036/Pharma Globenewswireen2026-06-10T11:58:10+01:00The Epilepsy Market Size across the 7MM was valued at nearly USD 9 billion in 2023 and is expected to grow at a CAGR of 7% during 2026-2036 https://www.pharmaglobenewswire.com/pde4-inhibitors-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-over-the-study-period-of-2020-2034-according-to-delveinsight/Pharma Globenewswireen2026-06-10T11:39:35+01:00PDE4 Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR over the study period of 2020-2034, according to DelveInsight https://www.pharmaglobenewswire.com/chronic-gout-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/Pharma Globenewswireen2026-06-10T11:24:35+01:00Chronic Gout Market Set to Witness Significant Growth Driven by Rising Prevalence, Pipeline Advancements, and Expanding Therapeutic Options Through 2034 https://www.pharmaglobenewswire.com/ductal-carcinoma-in-situ-therapeutics-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-according-to-delveinsight/Pharma Globenewswireen2026-06-10T10:58:07+01:00Ductal Carcinoma in Situ Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR by 2034, according to DelveInsight